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Objectives—Examine the effects of post-traumatic amnesia (PTA) duration on 
neuropsychological and global recovery from 1 to 6 months after complicated mild traumatic brain 
injury (cmTBI).
Participants—330 persons with cmTBI defined as Glasgow Coma Scale score of 13–15 in 
Emergency Department, with well-defined abnormalities on neuroimaging.
Methods—Enrollment within 24 hours of injury with follow-up at 1, 3, and 6 months.
Measures—Glasgow Outcome Scale-Extended, California Verbal Learning Test II, Controlled 
Oral Word Association Test. Duration of PTA was retrospectively measured with structured 
interview at 30 days post injury.
Results—Despite all having a Glasgow Coma Score of 13–15, a quarter of the sample had a PTA 
duration of greater than 7 days; half had PTA of 1–7 days. Both cognitive performance and GOS-E 
outcomes were strongly associated with time since injury and PTA duration, with those with PTA> 
1 week showing residual moderate disability at 6-month assessment.
Conclusions—Findings reinforce importance of careful measurement of duration of PTA to 
refine outcome prediction and allocation of resources to those with cmTBI. Future research would 
benefit from standardization in CT criteria and use of severity indices beyond GCS to characterize 
cmTBI.
Keywords
traumatic brain injury; cognitive function; outcome measures; post-traumatic amnesia
INTRODUCTION
Based on estimates from the Centers for Disease Control and Prevention, there are more 
than one million emergency department (ED) visits for head injury each year in the US, with 
approximately 300,000 resulting hospitalizations.1 The vast majority are so-called mild 
traumatic brain injuries (mTBI), which are at least tenfold more prevalent than more severe 
injuries.2 While the likelihood of favorable recovery from mTBI within a few months is 
high,3–5 a proportion of patients experience long-standing cognitive, emotional, and/ or 
somatic symptoms that interfere with work, school, and/or family responsibilities.6 Thus, it 
is likely that the societal burden resulting from mTBI is at least equivalent to that resulting 
from severe TBI, given the considerably higher prevalence of the former.2, 6
One common definition of mTBI, put forth by the American Congress of Rehabilitation 
Medicine (ACRM) in 1993, specifies a Glasgow Coma Scale (GCS) score of 13–15 in the 
ED and loss of consciousness (LOC) ≤ 30 minutes.7 While some loss or alteration of 
consciousness is necessary to signal a TBI by this definition, post-traumatic amnesia (PTA) 
must not exceed 24 hours for the TBI to be considered mild. However, it has become 
apparent that there are clinically important variations within the group of injuries that result 
in GCS 13–15, which may help to explain the diverse outcomes experienced by this group of 
patients. In 1990, Williams et al. used the term “complicated mild” TBI (cmTBI) to refer to 
cases where GCS is 13–15 but there are CT abnormalities such as contusions or other 
trauma-related brain lesions.8 Although the cmTBI patients in this sample did not differ 
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from mTBI patients on LOC or PTA duration, their 6-month outcomes were worse. This led 
the authors to suggest that an intracranial lesion should place such patients into the 
“moderate” severity category, or at least into a different category from those with 
uncomplicated mTBI. More recent work has suggested that as many as 30–50% of patients 
with TBI presenting to the ED with GCS 13–15 may have trauma-related intracranial 
pathology visible on CT.6, 9, 10
The research comparing outcomes of mTBI to those of cmTBI has been equivocal; it is 
difficult to synthesize findings due to the generally small samples and the differences among 
studies in how cmTBI was defined, the measures used (neuropsychological tests, symptom 
checklists, global outcome measures, etc.), and the intervals at which outcomes were 
measured, ranging from 1 week to 1 year. Several prospective9–11 and retrospective4 studies 
have reported no or very small differences between cmTBI and mTBI in neuropsychological 
test performance, return to work rates, or global outcomes. Others have found worse 
outcomes for cmTBI on global outcome measures12 or neuropsychological tests.13 Two 
reports from the ongoing TRACK-TBI project have reported worse global outcomes for 
cmTBI compared to mTBI at 3 months, but differences had attenuated by 6 months.6, 14
While all previous reports on cmTBI outcomes have used GCS 13–15 and positive CT 
findings as defining characteristics, there is variation in the literature as to the inclusion of 
other TBI severity indices, notably LOC (also known as Time to Follow Commands or TFC) 
and PTA duration. A few studies have used the ACRM criteria for both mTBI and cmTBI 
cases, meaning that LOC and PTA are brief for both groups and the only difference is the 
presence of visible brain pathology.10, 14 Most others have focused on GCS and CT findings 
to define the groups, and have not reported the other indices. LOC is difficult to measure 
accurately in these patients since by definition, they are conscious in the ED, and LOC 
duration would need to be determined by accounts of field rescue staff or other witnesses, all 
of whom may be unavailable. However, PTA duration has been shown to vary widely in 
patients who present to the ED with GCS 13–15, in many cases lasting well beyond the 24 
hours stipulated in the ACRM definition of mTBI.15 PTA duration is considered the most 
sensitive index of the degree of diffuse axonal injury (DAI)16 and can be measured 
prospectively, using serial testing, or retrospectively using structured interviewing to 
estimate the length of the gap in recall following the TBI. But a recent report pointed out 
that PTA is not routinely assessed in the ED, and that many patients who are “fully oriented” 
(GCS = 15) are found still to be in PTA when tested with more sensitive measures of 
anterograde memory.17 Thus, it is possible that some of the variable results in the cmTBI 
literature could be explained by differing amounts of DAI within the range insufficient to 
cause deep or prolonged unconsciousness, which could nonetheless combine with focal 
injuries to adversely affect outcomes.
A more comprehensive understanding of the determinants of cmTBI outcome is important 
because of its prevalence among so-called mild brain injuries, because of the current 
difficulty in predicting outcome for patients with this clinical presentation, and because 
some people with cmTBI may require more extensive rehabilitation services than are 
typically offered to them. In the current study, we performed a secondary analysis on a large 
sample of persons with cmTBI who had been enrolled in the 8-center COBRIT 
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neuroprotection trial.18, 19 Advantages of this dataset included capture of both 
neuropsychological and global outcomes at 3 time points within the first 6 months after 
injury; rigorous characterization of neuroimaging results used to diagnose cmTBI; and 
standardized assessment of PTA duration. We examined the trajectory of recovery in 2 
important cognitive domains as well as global outcome, hypothesizing that longer PTA 
would be associated with worse outcomes after controlling for other variables known to 
affect TBI outcome.
METHOD
Participants
Participants were a sub-group of those identified as having cmTBI in the COBRIT study, an 
8-center, placebo-controlled Phase III trial examining the neuroprotective effects of 
citicoline administered within 24 hours of injury.18, 19 COBRIT inclusion criteria were: non-
penetrating TBI of at least complicated mild severity (defined below); aged 18 (19 in 
Alabama) to 70; sufficiently fluent in English to complete neuropsychological testing; and 
able to provide consent by self or proxy within 24 hours of injury. Patients were excluded 
from COBRIT if they were unlikely to survive to follow-up due either to the TBI or 
associated injuries, pregnant, incarcerated, or had a history of significant psychiatric illness 
(e.g., schizophrenia, suicide attempt in the past year) or neurological disorder (e.g., previous 
TBI with hospitalization, stroke, dementia).
For the current study, we selected patients from the inert-placebo arm of COBRIT who had 
experienced cmTBI. Citicoline-treated participants were excluded because although the 
parent trial showed no neuroprotective benefit of citicoline, there was some indication that 
cmTBI patients did worse in the active drug condition.19 Thus, inclusion criteria for the 
present study were: assignment to the placebo arm of the trial; GCS of 13–15 in the ED; and 
evidence of one or more CT scan abnormalities at the time of study randomization, which 
took place within 24 hours of injury. A scan abnormality was defined as any of the 
following: ≥10 mm total diameter of all intraparenchymal hemorrhages; acute extra-axial 
hematoma thickness ≥5 mm; subarachnoid hemorrhage visible on at least two contiguous 5-
mm slices or at least three contiguous 3-mm slices; intraventricular hemorrhage present on 
two slices; or midline shift ≥5 mm. These criteria were established by a study team that 
included neurosurgeons, neurologists, and physiatrists, with input from neuroradiologists, so 
as to avoid enrolling patients with equivocal TBI into the COBRIT study19 and to minimize 
inter-observer variation across sites.20 All CT scans were read by neuroradiologists at the 
participating sites who had received training in the COBRIT study protocol. The scans were 
subsequently reviewed by a panel of neurosurgeons and neurologists associated with the 
study to ensure adherence to inclusion guidelines.
Measures
Outcome was assessed at 30 (+/− 7), 90 (+/− 10), and 180 (+/− 10) days post injury with a 
battery that included the following measures.
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Extended Glasgow Outcome Scale(GOS-E):21—The GOS-E consists of eight levels 
of functional recovery, ranging from Dead (0) to Good Recovery (8). Items comprising the 
scale focus on the capacity to care for oneself and function in the community, as well as 
effects of persistent TBI symptoms interfering with function. The GOS-E is commonly 
employed to measure functional recovery following TBI including cmTBI6, 12, 14 and has 
demonstrated good test-retest reliability (r = .92).22
California Verbal Learning Test-II:23—The CVLT-II requires the individual to learn a 
list of 16 words over 5 trials. For this study, we used the T score for the sum of the 5 
learning trials. The CVLT-II and its predecessor (CVLT) have proven to be sensitive 
measures of memory disorder after TBI,24, 25 and the revised form has good test-retest 
reliability (r = .82). 23 To minimize practice effects, the standard form of the CVLT-II was 
administered at the 30- and 180-day intervals and the alternate version at the 90-day interval.
Controlled Oral Word Association Test (COWAT):26—In this test of verbal 
generativity, subjects are allowed 60 seconds to say as many words as possible that begin 
with a specific letter of the alphabet. Verbal fluency is commonly impaired following TBI, 
probably reflecting executive dysfunction more than linguistic impairment.27, 28 In this 
study, the total number of words produced was analyzed after correction for age and 
education. The PRW version of the COWAT was administered at the 30-day interval and the 
CFL form at 90 and 180 days. These forms have been shown to be equivalent,29 and the 
COWAT overall has adequate test-retest reliability (r = .74).30
Post-Traumatic Amnesia—PTA duration was measured retrospectively using a 5–10-
minute structured interview in which a trained data collector assisted the participant in 
estimating the number of days or, if <1 day, the number of hours, between the TBI and 
resumption of continuous recall of events. The interview took place at the first follow-up 
assessment at which the participant achieved a score of greater than 75 on the Galveston 
Orientation and Amnesia Test (GOAT).31 In nearly all cases of cmTBI, this was 30 days post 
injury. This interview has been used in prior studies of TBI.32, 33 It has demonstrated 
construct validity in that PTA intervals based on the interview were shown to be 
monotonically related to psychiatric outcomes, with longer PTA predicting worse outcomes 
in the same cohort as studied in this investigation.34 In another study, PTA durations 
ascertained using the interview correlated well with PTA prospectively measured using serial 
orientation testing, even in patients interviewed months or years after TBI (n = 35; r = 0.68, 
p<.001).35 For this study we collapsed PTA durations into 3 levels: <24 hours (i.e., 
comparable to ACRM criterion for mTBI);7 1–7 days; and >7 days.
Procedures
The institutional review boards (IRB) of all participating sites approved the protocol and 
either the patients or their legally authorized representatives (LAR) provided written 
informed consent according to the local IRB rules for proxy consent. If an LAR consented 
originally, the participant directly consented for continued involvement upon recovery of 
decision-making capacity. Data collection was performed according to a manualized 
procedure. All data were double-scored at each site, and monthly teleconferences were held 
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among data collectors and investigators at each site to address questions of test 
administration, scoring, or coding. A Data Coordinating Center at Columbia University 
oversaw the trial, cleansed the data, and performed preliminary analyses. Upon completion 
of the COBRIT trial, de-identified data were provided to all participating sites.
Data Analysis
Chi-square tests were used to examine the associations of PTA with demographic variables 
and mechanism of injury. For the analyses of neuropsychological and global outcomes by 
PTA group, all outcome measures in the battery were treated as continuous variables. 
Predictors were all categorical. Descriptive analyses consisted of frequencies, means, and 
plots. Separate linear mixed effects models were used to evaluate each of the longitudinal 
outcomes. Preliminary model fitting evaluated demographic variables and mechanism of 
injury as predictors of each individual outcome. Potential confounding variables were 
selected based on best fit as assessed by Akaike’s information criteria.36 Next, PTA group 
was added to each of the models. Contrasts within the linear mixed effects analysis 
compared the PTA groups and the change between consecutive assessments. Participants 
were excluded from the analysis if they were missing all 3 assessments, racial/ethnic group, 
education, or PTA duration. As is common in studies of TBI, participants who could not 
perform the tests due to cognitive difficulties associated with the TBI were assigned 1 raw 
score unit worse than the lowest observed score on the CVLT-II and COWAT.37, 38 Ten 
participants could not perform either neuropsychological measure at 30 days, and one could 
not perform COWAT. One participant could not perform either measure at 90 days due to 
cognitive difficulties. One participant died before the 180-day evaluation. His data were 
included until death, and then assigned a value 1 lower than that assigned to those too 
cognitively impaired to take the CVLT-II and COWAT. This was done because unlike the 
GOS-E, the neuropsychological measures do not have a score indicating death, and we 
preferred to maintain this participant’s data on all measures via use of arbitrarily low scores.
RESULTS
The COBRIT study included 401 participants with cmTBI who were randomly assigned to 
the placebo group. Of these, 53 individuals had no outcome assessments; 6 were missing 
race/ ethnicity or education data; and 12 had unknown PTA, leaving a sample of 330. 
Analyses were separately conducted for GOS-E (n=330), COWAT (n=328) and CVLT-II 
(n=317).
Demographics and mechanism of injury for the PTA groups are summarized in Table 1. It is 
apparent that there was a wide range of PTA duration in this sample, despite all participants 
having an ED GCS of 13–15. Only 25% of the sample had PTA < 1 day, while 47% had 
PTA of 1–7 days and 28% reported > 7 days. Not surprisingly, participants involved in motor 
vehicle collisions were significantly more likely to have longer PTA durations than those 
injured by falls or assault. PTA duration was not significantly associated with age, sex, race/ 
ethnicity, or education.
Figure 1 displays the 3 outcome measures for each PTA group at each outcome assessment. 
It may be seen that the shortest PTA group has the highest, and the longest PTA group the 
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lowest, mean score at each time point on all 3 measures. For the GOS-E, at 1 month after 
injury, participants with PTA > 7 days were functioning, on average, in the moderate to 
severe disability range, while those experiencing briefer PTA duration were mostly in the 
moderate disability category. The shorter PTA groups improved to the good recovery range 
by 6 months post-injury, while the longest duration PTA group had only reached the upper 
moderate disability range on average. Clinically, upper moderate disability means that there 
are restrictions in the capacity to work at the premorbid level, and/ or limitations in social/ 
leisure activity participation, and/ or frequent disruption in family or friendship relationships 
attributable to the injury.
The pattern was similar overall for the neuropsychological measures. For the CVLT-II, total 
learning performance for the > 7 days PTA group fell within the borderline impaired range 
at 30 days on average, and scores increased to the average range by 6 months post-injury. 
Those with shorter duration PTA fell within the average range even at 1 month, but still 
increased over the next two administrations; the PTA <1 day group reached the high average 
range at 6 months after injury. Finally, on the COWAT, the long duration PTA group 
exhibited low average performance at 1 month that increased to average performance in 
subsequent administrations. The shorter PTA groups demonstrated average performance on 
the COWAT at all intervals.
Post-hoc rank order correlations among the 3 outcome measures were calculated in an 
attempt to shed light on the apparent discrepancy between cognitive and functional recovery, 
particularly in the group with the longest PTA duration. At the 180-day evaluation, CVLT-II 
and COWAT scores were moderately intercorrelated (rho = .42, p<.001). GOS-E scores were 
more weakly correlated with either cognitive measure (rho = .22 for CVLT-II, .15 for 
COWAT), although both were significant at p<.01 given the large sample size.
The initial mixed models indicated that age and race were potential predictors for GOS-E; 
age, sex, and education were potential confounders for COWAT; and age, race, and 
education were potential confounders for CVLT-II. Addition of PTA as a predictor 
significantly improved all three models. Table 2 gives the coefficients for the three models. 
Each outcome was strongly related to both time of observation and PTA group (each p 
<0.002). Contrasts are shown in Table 3. Compared to 30 days, scores improved 
significantly by 90 days and again from 90 to 180 days for each measure. Those with PTA 
>7 days had significantly worse outcome than either those with PTA <1 day or PTA 1–7 
days on each measure (each p <0.001). Those with PTA <1 day had significantly better 
outcome than those with 1–7 days of PTA on GOS-E and CVLT-II, but the differences were 
less robust.
DISCUSSION
In a large, prospectively followed cohort of persons with cmTBI, all with GCS 13–15 in the 
ED and strictly defined CT scan abnormality, we observed a wide range of PTA duration that 
was strongly related to neuropsychological and global outcome within the first 6 months of 
injury. Only a quarter of the sample had resolution of PTA within 24 hours, the duration 
typically associated with mild TBI.7 Nearly half experienced PTA of 1–7 days, with the 
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remaining 28% reporting more than a week of PTA. That longer PTA duration was 
associated with worse performance on tests of memory and verbal fluency, in addition to 
worse global outcome, suggests that PTA is an important measure in cases of cmTBI, just as 
in uncomplicated mild TBI.15 From a research perspective, including PTA along with GCS 
and neuroimaging may help to reduce the discrepancies among study findings as well as 
helping us to understand the relative contributions of diffuse and focal brain injury to 
ultimate outcome. Clinically, ascertaining PTA in addition to GCS and CT findings should 
assist both in predicting recovery and in recommending rehabilitation services in cases of 
cmTBI. A brief retrospective interview such as the one described here could be administered 
shortly after the resolution of PTA or at a clinic follow-up and is substantially less labor-
intensive than prospective tracking of anterograde learning ability, particularly in a busy ED 
or acute hospital setting. While PTA duration is potentially useful as a predictor in all cases 
of TBI, it is especially important to ascertain when the mechanism of injury is motor vehicle 
collision, as our data confirm that prolonged PTA (and presumably, more DAI) is more 
likely with this cause of TBI.
It is important to note that for all PTA duration groups, we observed continued improvement 
on all measures between all pairs of time points used in this investigation (1, 3, and 6 
months). This attests to the sensitivity of the measures selected as well as the need for 
continued follow-up of cmTBI patients. Specifically, it would be useful for future research, 
as well as clinical services, to follow persons with cmTBI for longer than 6 months to 
capture the full recovery trajectory. This is particularly important for those with longer PTA, 
as the average participant with duration >1 week still reported limitations in social and/ or 
vocational functioning at 6 months after injury.
Regarding this last point, one limitation of this study is that we lack detailed information 
that might help to explain the residual disability of the group with the longest PTA. 
Although correlations between GOS-E and cognitive scores at 6 months were statistically 
significant, they were small in magnitude. In TBI it is not unusual to find normal 
psychometric test performance in the face of greater difficulty in less structured, real-world 
situations.39 Other unmeasured factors could also be contributing to the GOS-E outcomes; 
these could include persistent post-concussive symptoms such as headache or insomnia, 
post-traumatic stress, irritability, or other emotional dysfunction; or cognitive dysfunction 
that could have been picked up by the use of more demanding measures, e.g., of 
information-processing speed.
Our findings may be difficult to compare to previous reports on cmTBI due to differences in 
the definition of the samples, especially with regard to the CT abnormalities. Our sample 
may have been skewed toward more serious cases of cmTBI due to the stringent CT scan 
criteria we employed. For example, a minor subarachnoid hemorrhage would have excluded 
a patient from the COBRIT study but perhaps not from other investigations of this 
population. However, many studies of cmTBI do not specify the CT abnormalities that 
qualify a patient for inclusion. In future, we recommend clear and precise definitions of CT 
criteria for cmTBI to improve the cross-walk between studies. To the extent that studies may 
be compared, our findings generally comport with previous work showing scores in the 
normal range at 3–6 months after cmTBI with respect to CVLT-II total learning40 and 
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COWAT performance.8 However, as documented in this study, those with PTA >7 days 
achieve these results more slowly and even at 6 months are not performing as well as those 
with shorter PTA.
Other than those noted above, several limitations of this study must be acknowledged. The 
study was limited to persons with cmTBI and lacked any sort of control or comparison 
group. A comparison group of patients with uncomplicated mTBI, as in the work of Yuh and 
colleagues,14 would have allowed us to estimate the effects of focal cerebral injury; however, 
unless the ACRM definition had been disregarded and PTA duration allowed to vary, this 
comparison would have offered little information as to the effects of diffuse injury that may 
prolong alteration of consciousness. An uninjured control group may have helped to assess 
the effects of serial testing on the cognitive measures; however, practice effects were 
minimized by use of equivalent alternate forms. Finally, participants in the current study 
were enrolled in the placebo arm of a treatment study, and there may have been an 
expectation of improvement that affected performance.
In conclusion, these findings highlight the importance of assessing PTA duration to refine 
outcome predictions and rehabilitation treatment recommendations for people who 
experience cmTBI. Those with PTA > 1 week, in particular, may be at risk for residual 
disability as long as 6 months following injury. Specifying both PTA duration and CT 
criteria for cases of cmTBI will help to improve both comparisons across studies of this 
population and future clinical service provision.
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Figure 1. 
Outcome measures for each PTA group. (A) Performance on the GOS-E based on time and 
PTA duration. (B) Performance on the learning trials of the CVLT-II based on time and PTA 
duration using T score. (C) Performance on the COWAT based on time and PTA duration 
with raw score adjusted for age and education. Observed values include death. Error bars are 
±1 SE of the mean. GOS-E indicates Glasgow Outcome Scale-Extended; CVLT-II, 
California Verbal Learning Test II; COWAT, Controlled Oral Word Association Test.
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Table 1
Demographics and mechanism of injury by PTA group
PTA <1 day n = 84 PTA 1-7 days n = 155 PTA >7 days n = 91
Age
18–30 21 (25%) 44 (28%) 20 (22%)
>30–45 14 (17%) 40 (26%) 26 (29%)
>45–60 29 (35%) 49 (32%) 31 (34%)
>60 20 (24%) 22 (14%) 14 (15%)
Sex
Female 17 (20%) 47 (30%) 29 (32%)
Male 67 (80%) 108 (70%) 62 (68%)
Race/Ethnicity
White 64 (76%) 126 (81%) 76 (84%)
Black/African American 13 (15%) 22 (14%) 12 (13%)
Hispanic 7 (8%) 7 (5%) 3 (3%)
Education
Some elementary school or high school 11 (13%) 20 (13%) 13 (14%)
High school graduate, GED, technical, vocational, or trade school 27 (32%) 64 (41%) 36 (40%)
Some college 23 (27%) 42 (27%) 20 (22%)
College graduate, some graduate school, or completed graduate 
school
23 (27%) 29 (19%) 21 (23%)
Missing/Unknown 0 (0%) 0 (0%) 1 (1%)
Mechanism of Injury*
Motor vehicle collision 26 (31%) 73 (47%) 60 (66%)
Fall from moving object 14 (17%) 20 (13%) 3 (3%)
Fall from stationary object 24 (29%) 39 (25%) 20 (22%)
Assault (Intentional Injury) 15 (18%) 16 (10%) 6 (7%)
Other 5 (6%) 7 (5%) 2 (2%)
Abbreviations: PTA, post-traumatic amnesia
*Significantly associated with PTA at p < .001
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Table 2
Final longitudinal model for GOS-E, COWAT, and CVLT-II at 30, 90, and 180 days after injury
GOS-E Estimate Lower 95% CI Upper 95% CI p-valuea
Time <0.001
180 days (vs. 30 days) 1.20 1.06 1.34 <0.001
90 days (vs. 30 days) 0.86 0.73 1.00 <0.001
PTA <0.001
<1 day (vs. >7 days) 1.42 1.12 1.71 <0.001
1–7 days (vs. >7 days) 1.05 0.79 1.31 <0.001
Age 0.001
>60 (vs. 18–30) −0.57 −0.91 −0.23 0.001
46–60 (vs. 18–30) −0.46 −0.76 −0.17 0.002
31–45 (vs. 18–30) −0.10 −0.41 0.21 0.522
Race 0.010
Black (vs. White) −0.48 −0.80 −0.17 0.003
Hispanic (vs. White) 0.03 −0.47 0.53 0.913
COWAT Estimate Lower 95% CI Upper 95% CI p-value
Time <0.001
180 days (vs. 30 days) 6.58 5.51 7.66 <0.001
90 days (vs. 30 days) 5.54 4.65 6.43 <0.001
PTA <0.001
<1 day (vs. >7 days) 6.34 3.40 9.28 <0.001
1–7 days (vs. >7 days) 4.05 1.52 6.59 0.002
Education <0.001
College (vs. no HS) 9.59 5.85 13.33 <0.001
Some college (vs. no HS) 8.31 4.72 11.90 <0.001
HS/Other (vs. no HS) 3.20 −0.18 6.58 0.063
Sex (Female vs. Male) 2.50 0.08 4.91 0.043
Age 0.016
>60 (vs. 18–30) −5.57 −8.96 −2.17 0.001
46–60 (vs. 18–30) −2.41 −5.20 0.39 0.091
31–45 (vs. 18–30) −2.08 −5.11 0.95 0.178
CVLT-II Estimate Lower 95% CI Upper 95% CI p-value
Time <0.001
180 days (vs. 30 days) 11.11 9.75 12.47 <0.001
90 days (vs. 30 days) 6.04 4.73 7.35 <0.001
PTA <0.001
<1 day (vs. >7 days) 7.55 4.35 10.75 <0.001
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CVLT-II Estimate Lower 95% CI Upper 95% CI p-value
1–7 days (vs. >7 days) 4.54 1.76 7.32 0.001
Race <0.001
Black (vs. White) −6.32 −9.68 −2.97 <0.001
Hispanic (vs. White) −6.50 −11.87 −1.12 0.018
Education <0.001
College (vs. no HS) 10.26 6.17 14.34 <0.001
Some college (vs. no HS) 8.23 4.27 12.20 <0.001
HS/Other (vs. no HS) 2.77 −0.98 6.39 0.150
Age 0.053
>60 (vs. 18–30) −3.56 −7.27 0.16 0.060
46–60 (vs. 18–30) −1.73 −4.75 1.28 0.260
31–45 (vs. 18–30) −4.37 −7.69 −1.05 0.010
Abbreviations: GOS-E, Glasgow Outcome Scale-Extended; CI, confidence interval; PTA, post-traumatic amnesia; HS, high school; COWAT, 
Controlled Oral Word Association Test; CVLT-II, California Verbal Learning Test II.
a
The p-value on the line with the variable name reflects the entire multicategory variable, whereas the p-value on the line with a category reflects 
the comparison of that category with the reference category (indicated after ‘vs.’).
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Table 3
Comparison of PTA groups and assessment times
GOS-E
Contrasts Difference Lower 95% CI Upper 95% CI p-value
<1 day vs1–7 days 0.37 0.10 0.64 0.007
<1 day vs >7 days 1.42 1.12 1.71 <0.001
1–7 days vs >7 days 1.05 0.79 1.31 <0.001
30 vs 90 days 0.86 0.73 1.00 <0.001
90 vs 180 days 0.33 0.20 0.47 <0.001
COWAT
Contrasts Difference Lower 95% CI Upper 95% CI p-value
<1 day vs 1–7 days 2.28 −0.35 4.91 0.089
<1 day vs >7 days 6.34 3.40 9.28 <0.001
1–7 days vs >7 days 4.05 1.52 6.59 0.002
30 vs 90 days 5.54 4.65 6.43 <0.001
90 vs 180 days 1.04 0.04 2.05 0.043
CVLT-II
Contrasts Difference Lower 95% CI Upper 95% CI p-value
<1 day vs 1–7 days 3.01 0.15 5.87 0.039
<1 day vs >7 days 7.75 4.35 10.75 <0.001
1–7 days vs >7 days 4.54 1.76 7.32 0.001
30 vs 90 days 6.04 4.73 7.35 <0.001
90 vs 180 days 5.07 3.71 6.42 <0.001
Abbreviations: GOS-E, Glasgow Outcome Scale-Extended; CI, confidence interval; PTA, post-traumatic amnesia; COWAT, Controlled Oral Word 
Association Test; CVLT-II, California Verbal Learning Test II.
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